Publications

Surveillance of omadacycline in vitro activity against 35,000 bacterial clinical isolates from the United States (2019–2023). Lead author: Michael D. Huband, IDWeek 2024, October 16-19, Los Angeles, CA, USA

Poster #P411

View Poster